Global Oligonucleotide Therapy Market Research Report 2024(Status and Outlook)
Report Overview:
Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.
Although several types of oligonucleotide therapies exist, five of them are compared here, including the ones targeting nucleic acids (such as mRNA) or proteins, as well as others intended for stimulation of the immune system. DDS is generally used with oligonucleotide therapy, as it is difficult for these molecules to penetrate cell membrane when administered on their own.
The Global Oligonucleotide Therapy Market Size was estimated at USD 3847.20 million in 2023 and is projected to reach USD 4756.67 million by 2029, exhibiting a CAGR of 3.60% during the forecast period.
This report provides a deep insight into the global Oligonucleotide Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oligonucleotide Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oligonucleotide Therapy market in any manner.
Global Oligonucleotide Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Alnylam Pharmaceuticals Inc.
Biogen
Dynavax Technologies Corp.
Merck and Co.
Miragen Therapeuutics Inc.
Sarepta Therapeutics Inc.
GlaxoSmithKline
Pfizer
Gilead Sciences
Market Segmentation (by Type)
Antisense Oligonucleotide
Aptamer
Others
Market Segmentation (by Application)
Infectious Diseases
Oncology
Neurodegenerative Disorders
Cardiovascular Diseases
Kidney Diseases
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oligonucleotide Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.
Although several types of oligonucleotide therapies exist, five of them are compared here, including the ones targeting nucleic acids (such as mRNA) or proteins, as well as others intended for stimulation of the immune system. DDS is generally used with oligonucleotide therapy, as it is difficult for these molecules to penetrate cell membrane when administered on their own.
The Global Oligonucleotide Therapy Market Size was estimated at USD 3847.20 million in 2023 and is projected to reach USD 4756.67 million by 2029, exhibiting a CAGR of 3.60% during the forecast period.
This report provides a deep insight into the global Oligonucleotide Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oligonucleotide Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oligonucleotide Therapy market in any manner.
Global Oligonucleotide Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Alnylam Pharmaceuticals Inc.
Biogen
Dynavax Technologies Corp.
Merck and Co.
Miragen Therapeuutics Inc.
Sarepta Therapeutics Inc.
GlaxoSmithKline
Pfizer
Gilead Sciences
Market Segmentation (by Type)
Antisense Oligonucleotide
Aptamer
Others
Market Segmentation (by Application)
Infectious Diseases
Oncology
Neurodegenerative Disorders
Cardiovascular Diseases
Kidney Diseases
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Oligonucleotide Therapy Market
- Overview of the regional outlook of the Oligonucleotide Therapy Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oligonucleotide Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Oligonucleotide Therapy
1.2 Key Market Segments
1.2.1 Oligonucleotide Therapy Segment by Type
1.2.2 Oligonucleotide Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OLIGONUCLEOTIDE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oligonucleotide Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Oligonucleotide Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OLIGONUCLEOTIDE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Oligonucleotide Therapy Sales by Manufacturers (2019-2024)
3.2 Global Oligonucleotide Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Oligonucleotide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oligonucleotide Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oligonucleotide Therapy Sales Sites, Area Served, Product Type
3.6 Oligonucleotide Therapy Market Competitive Situation and Trends
3.6.1 Oligonucleotide Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oligonucleotide Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 OLIGONUCLEOTIDE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Oligonucleotide Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OLIGONUCLEOTIDE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 OLIGONUCLEOTIDE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oligonucleotide Therapy Sales Market Share by Type (2019-2024)
6.3 Global Oligonucleotide Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Oligonucleotide Therapy Price by Type (2019-2024)
7 OLIGONUCLEOTIDE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oligonucleotide Therapy Market Sales by Application (2019-2024)
7.3 Global Oligonucleotide Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Oligonucleotide Therapy Sales Growth Rate by Application (2019-2024)
8 OLIGONUCLEOTIDE THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Oligonucleotide Therapy Sales by Region
8.1.1 Global Oligonucleotide Therapy Sales by Region
8.1.2 Global Oligonucleotide Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Oligonucleotide Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oligonucleotide Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oligonucleotide Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oligonucleotide Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oligonucleotide Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Alnylam Pharmaceuticals Inc.
9.1.1 Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Basic Information
9.1.2 Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Product Overview
9.1.3 Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Product Market Performance
9.1.4 Alnylam Pharmaceuticals Inc. Business Overview
9.1.5 Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy SWOT Analysis
9.1.6 Alnylam Pharmaceuticals Inc. Recent Developments
9.2 Biogen
9.2.1 Biogen Oligonucleotide Therapy Basic Information
9.2.2 Biogen Oligonucleotide Therapy Product Overview
9.2.3 Biogen Oligonucleotide Therapy Product Market Performance
9.2.4 Biogen Business Overview
9.2.5 Biogen Oligonucleotide Therapy SWOT Analysis
9.2.6 Biogen Recent Developments
9.3 Dynavax Technologies Corp.
9.3.1 Dynavax Technologies Corp. Oligonucleotide Therapy Basic Information
9.3.2 Dynavax Technologies Corp. Oligonucleotide Therapy Product Overview
9.3.3 Dynavax Technologies Corp. Oligonucleotide Therapy Product Market Performance
9.3.4 Dynavax Technologies Corp. Oligonucleotide Therapy SWOT Analysis
9.3.5 Dynavax Technologies Corp. Business Overview
9.3.6 Dynavax Technologies Corp. Recent Developments
9.4 Merck and Co.
9.4.1 Merck and Co. Oligonucleotide Therapy Basic Information
9.4.2 Merck and Co. Oligonucleotide Therapy Product Overview
9.4.3 Merck and Co. Oligonucleotide Therapy Product Market Performance
9.4.4 Merck and Co. Business Overview
9.4.5 Merck and Co. Recent Developments
9.5 Miragen Therapeuutics Inc.
9.5.1 Miragen Therapeuutics Inc. Oligonucleotide Therapy Basic Information
9.5.2 Miragen Therapeuutics Inc. Oligonucleotide Therapy Product Overview
9.5.3 Miragen Therapeuutics Inc. Oligonucleotide Therapy Product Market Performance
9.5.4 Miragen Therapeuutics Inc. Business Overview
9.5.5 Miragen Therapeuutics Inc. Recent Developments
9.6 Sarepta Therapeutics Inc.
9.6.1 Sarepta Therapeutics Inc. Oligonucleotide Therapy Basic Information
9.6.2 Sarepta Therapeutics Inc. Oligonucleotide Therapy Product Overview
9.6.3 Sarepta Therapeutics Inc. Oligonucleotide Therapy Product Market Performance
9.6.4 Sarepta Therapeutics Inc. Business Overview
9.6.5 Sarepta Therapeutics Inc. Recent Developments
9.7 GlaxoSmithKline
9.7.1 GlaxoSmithKline Oligonucleotide Therapy Basic Information
9.7.2 GlaxoSmithKline Oligonucleotide Therapy Product Overview
9.7.3 GlaxoSmithKline Oligonucleotide Therapy Product Market Performance
9.7.4 GlaxoSmithKline Business Overview
9.7.5 GlaxoSmithKline Recent Developments
9.8 Pfizer
9.8.1 Pfizer Oligonucleotide Therapy Basic Information
9.8.2 Pfizer Oligonucleotide Therapy Product Overview
9.8.3 Pfizer Oligonucleotide Therapy Product Market Performance
9.8.4 Pfizer Business Overview
9.8.5 Pfizer Recent Developments
9.9 Gilead Sciences
9.9.1 Gilead Sciences Oligonucleotide Therapy Basic Information
9.9.2 Gilead Sciences Oligonucleotide Therapy Product Overview
9.9.3 Gilead Sciences Oligonucleotide Therapy Product Market Performance
9.9.4 Gilead Sciences Business Overview
9.9.5 Gilead Sciences Recent Developments
10 OLIGONUCLEOTIDE THERAPY MARKET FORECAST BY REGION
10.1 Global Oligonucleotide Therapy Market Size Forecast
10.2 Global Oligonucleotide Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oligonucleotide Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Oligonucleotide Therapy Market Size Forecast by Region
10.2.4 South America Oligonucleotide Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oligonucleotide Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Oligonucleotide Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Oligonucleotide Therapy by Type (2025-2030)
11.1.2 Global Oligonucleotide Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Oligonucleotide Therapy by Type (2025-2030)
11.2 Global Oligonucleotide Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Oligonucleotide Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Oligonucleotide Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Oligonucleotide Therapy
1.2 Key Market Segments
1.2.1 Oligonucleotide Therapy Segment by Type
1.2.2 Oligonucleotide Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OLIGONUCLEOTIDE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oligonucleotide Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Oligonucleotide Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OLIGONUCLEOTIDE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Oligonucleotide Therapy Sales by Manufacturers (2019-2024)
3.2 Global Oligonucleotide Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Oligonucleotide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oligonucleotide Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oligonucleotide Therapy Sales Sites, Area Served, Product Type
3.6 Oligonucleotide Therapy Market Competitive Situation and Trends
3.6.1 Oligonucleotide Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oligonucleotide Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 OLIGONUCLEOTIDE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Oligonucleotide Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OLIGONUCLEOTIDE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 OLIGONUCLEOTIDE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oligonucleotide Therapy Sales Market Share by Type (2019-2024)
6.3 Global Oligonucleotide Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Oligonucleotide Therapy Price by Type (2019-2024)
7 OLIGONUCLEOTIDE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oligonucleotide Therapy Market Sales by Application (2019-2024)
7.3 Global Oligonucleotide Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Oligonucleotide Therapy Sales Growth Rate by Application (2019-2024)
8 OLIGONUCLEOTIDE THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Oligonucleotide Therapy Sales by Region
8.1.1 Global Oligonucleotide Therapy Sales by Region
8.1.2 Global Oligonucleotide Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Oligonucleotide Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oligonucleotide Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oligonucleotide Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oligonucleotide Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oligonucleotide Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Alnylam Pharmaceuticals Inc.
9.1.1 Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Basic Information
9.1.2 Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Product Overview
9.1.3 Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Product Market Performance
9.1.4 Alnylam Pharmaceuticals Inc. Business Overview
9.1.5 Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy SWOT Analysis
9.1.6 Alnylam Pharmaceuticals Inc. Recent Developments
9.2 Biogen
9.2.1 Biogen Oligonucleotide Therapy Basic Information
9.2.2 Biogen Oligonucleotide Therapy Product Overview
9.2.3 Biogen Oligonucleotide Therapy Product Market Performance
9.2.4 Biogen Business Overview
9.2.5 Biogen Oligonucleotide Therapy SWOT Analysis
9.2.6 Biogen Recent Developments
9.3 Dynavax Technologies Corp.
9.3.1 Dynavax Technologies Corp. Oligonucleotide Therapy Basic Information
9.3.2 Dynavax Technologies Corp. Oligonucleotide Therapy Product Overview
9.3.3 Dynavax Technologies Corp. Oligonucleotide Therapy Product Market Performance
9.3.4 Dynavax Technologies Corp. Oligonucleotide Therapy SWOT Analysis
9.3.5 Dynavax Technologies Corp. Business Overview
9.3.6 Dynavax Technologies Corp. Recent Developments
9.4 Merck and Co.
9.4.1 Merck and Co. Oligonucleotide Therapy Basic Information
9.4.2 Merck and Co. Oligonucleotide Therapy Product Overview
9.4.3 Merck and Co. Oligonucleotide Therapy Product Market Performance
9.4.4 Merck and Co. Business Overview
9.4.5 Merck and Co. Recent Developments
9.5 Miragen Therapeuutics Inc.
9.5.1 Miragen Therapeuutics Inc. Oligonucleotide Therapy Basic Information
9.5.2 Miragen Therapeuutics Inc. Oligonucleotide Therapy Product Overview
9.5.3 Miragen Therapeuutics Inc. Oligonucleotide Therapy Product Market Performance
9.5.4 Miragen Therapeuutics Inc. Business Overview
9.5.5 Miragen Therapeuutics Inc. Recent Developments
9.6 Sarepta Therapeutics Inc.
9.6.1 Sarepta Therapeutics Inc. Oligonucleotide Therapy Basic Information
9.6.2 Sarepta Therapeutics Inc. Oligonucleotide Therapy Product Overview
9.6.3 Sarepta Therapeutics Inc. Oligonucleotide Therapy Product Market Performance
9.6.4 Sarepta Therapeutics Inc. Business Overview
9.6.5 Sarepta Therapeutics Inc. Recent Developments
9.7 GlaxoSmithKline
9.7.1 GlaxoSmithKline Oligonucleotide Therapy Basic Information
9.7.2 GlaxoSmithKline Oligonucleotide Therapy Product Overview
9.7.3 GlaxoSmithKline Oligonucleotide Therapy Product Market Performance
9.7.4 GlaxoSmithKline Business Overview
9.7.5 GlaxoSmithKline Recent Developments
9.8 Pfizer
9.8.1 Pfizer Oligonucleotide Therapy Basic Information
9.8.2 Pfizer Oligonucleotide Therapy Product Overview
9.8.3 Pfizer Oligonucleotide Therapy Product Market Performance
9.8.4 Pfizer Business Overview
9.8.5 Pfizer Recent Developments
9.9 Gilead Sciences
9.9.1 Gilead Sciences Oligonucleotide Therapy Basic Information
9.9.2 Gilead Sciences Oligonucleotide Therapy Product Overview
9.9.3 Gilead Sciences Oligonucleotide Therapy Product Market Performance
9.9.4 Gilead Sciences Business Overview
9.9.5 Gilead Sciences Recent Developments
10 OLIGONUCLEOTIDE THERAPY MARKET FORECAST BY REGION
10.1 Global Oligonucleotide Therapy Market Size Forecast
10.2 Global Oligonucleotide Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oligonucleotide Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Oligonucleotide Therapy Market Size Forecast by Region
10.2.4 South America Oligonucleotide Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oligonucleotide Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Oligonucleotide Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Oligonucleotide Therapy by Type (2025-2030)
11.1.2 Global Oligonucleotide Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Oligonucleotide Therapy by Type (2025-2030)
11.2 Global Oligonucleotide Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Oligonucleotide Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Oligonucleotide Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oligonucleotide Therapy Market Size Comparison by Region (M USD)
Table 5. Global Oligonucleotide Therapy Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Oligonucleotide Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Oligonucleotide Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Oligonucleotide Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapy as of 2022)
Table 10. Global Market Oligonucleotide Therapy Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Oligonucleotide Therapy Sales Sites and Area Served
Table 12. Manufacturers Oligonucleotide Therapy Product Type
Table 13. Global Oligonucleotide Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Oligonucleotide Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oligonucleotide Therapy Market Challenges
Table 22. Global Oligonucleotide Therapy Sales by Type (Kilotons)
Table 23. Global Oligonucleotide Therapy Market Size by Type (M USD)
Table 24. Global Oligonucleotide Therapy Sales (Kilotons) by Type (2019-2024)
Table 25. Global Oligonucleotide Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Oligonucleotide Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Oligonucleotide Therapy Market Size Share by Type (2019-2024)
Table 28. Global Oligonucleotide Therapy Price (USD/Ton) by Type (2019-2024)
Table 29. Global Oligonucleotide Therapy Sales (Kilotons) by Application
Table 30. Global Oligonucleotide Therapy Market Size by Application
Table 31. Global Oligonucleotide Therapy Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Oligonucleotide Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Oligonucleotide Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Oligonucleotide Therapy Market Share by Application (2019-2024)
Table 35. Global Oligonucleotide Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Oligonucleotide Therapy Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Oligonucleotide Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Oligonucleotide Therapy Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Oligonucleotide Therapy Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Oligonucleotide Therapy Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Oligonucleotide Therapy Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Oligonucleotide Therapy Sales by Region (2019-2024) & (Kilotons)
Table 43. Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Basic Information
Table 44. Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Product Overview
Table 45. Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Alnylam Pharmaceuticals Inc. Business Overview
Table 47. Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy SWOT Analysis
Table 48. Alnylam Pharmaceuticals Inc. Recent Developments
Table 49. Biogen Oligonucleotide Therapy Basic Information
Table 50. Biogen Oligonucleotide Therapy Product Overview
Table 51. Biogen Oligonucleotide Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Biogen Business Overview
Table 53. Biogen Oligonucleotide Therapy SWOT Analysis
Table 54. Biogen Recent Developments
Table 55. Dynavax Technologies Corp. Oligonucleotide Therapy Basic Information
Table 56. Dynavax Technologies Corp. Oligonucleotide Therapy Product Overview
Table 57. Dynavax Technologies Corp. Oligonucleotide Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Dynavax Technologies Corp. Oligonucleotide Therapy SWOT Analysis
Table 59. Dynavax Technologies Corp. Business Overview
Table 60. Dynavax Technologies Corp. Recent Developments
Table 61. Merck and Co. Oligonucleotide Therapy Basic Information
Table 62. Merck and Co. Oligonucleotide Therapy Product Overview
Table 63. Merck and Co. Oligonucleotide Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Merck and Co. Business Overview
Table 65. Merck and Co. Recent Developments
Table 66. Miragen Therapeuutics Inc. Oligonucleotide Therapy Basic Information
Table 67. Miragen Therapeuutics Inc. Oligonucleotide Therapy Product Overview
Table 68. Miragen Therapeuutics Inc. Oligonucleotide Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Miragen Therapeuutics Inc. Business Overview
Table 70. Miragen Therapeuutics Inc. Recent Developments
Table 71. Sarepta Therapeutics Inc. Oligonucleotide Therapy Basic Information
Table 72. Sarepta Therapeutics Inc. Oligonucleotide Therapy Product Overview
Table 73. Sarepta Therapeutics Inc. Oligonucleotide Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Sarepta Therapeutics Inc. Business Overview
Table 75. Sarepta Therapeutics Inc. Recent Developments
Table 76. GlaxoSmithKline Oligonucleotide Therapy Basic Information
Table 77. GlaxoSmithKline Oligonucleotide Therapy Product Overview
Table 78. GlaxoSmithKline Oligonucleotide Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Recent Developments
Table 81. Pfizer Oligonucleotide Therapy Basic Information
Table 82. Pfizer Oligonucleotide Therapy Product Overview
Table 83. Pfizer Oligonucleotide Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Pfizer Business Overview
Table 85. Pfizer Recent Developments
Table 86. Gilead Sciences Oligonucleotide Therapy Basic Information
Table 87. Gilead Sciences Oligonucleotide Therapy Product Overview
Table 88. Gilead Sciences Oligonucleotide Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Gilead Sciences Business Overview
Table 90. Gilead Sciences Recent Developments
Table 91. Global Oligonucleotide Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 92. Global Oligonucleotide Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Oligonucleotide Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 94. North America Oligonucleotide Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Oligonucleotide Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 96. Europe Oligonucleotide Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Oligonucleotide Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 98. Asia Pacific Oligonucleotide Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Oligonucleotide Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 100. South America Oligonucleotide Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Oligonucleotide Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Oligonucleotide Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Oligonucleotide Therapy Sales Forecast by Type (2025-2030) & (Kilotons)
Table 104. Global Oligonucleotide Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Oligonucleotide Therapy Price Forecast by Type (2025-2030) & (USD/Ton)
Table 106. Global Oligonucleotide Therapy Sales (Kilotons) Forecast by Application (2025-2030)
Table 107. Global Oligonucleotide Therapy Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oligonucleotide Therapy Market Size Comparison by Region (M USD)
Table 5. Global Oligonucleotide Therapy Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Oligonucleotide Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Oligonucleotide Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Oligonucleotide Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapy as of 2022)
Table 10. Global Market Oligonucleotide Therapy Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Oligonucleotide Therapy Sales Sites and Area Served
Table 12. Manufacturers Oligonucleotide Therapy Product Type
Table 13. Global Oligonucleotide Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Oligonucleotide Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oligonucleotide Therapy Market Challenges
Table 22. Global Oligonucleotide Therapy Sales by Type (Kilotons)
Table 23. Global Oligonucleotide Therapy Market Size by Type (M USD)
Table 24. Global Oligonucleotide Therapy Sales (Kilotons) by Type (2019-2024)
Table 25. Global Oligonucleotide Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Oligonucleotide Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Oligonucleotide Therapy Market Size Share by Type (2019-2024)
Table 28. Global Oligonucleotide Therapy Price (USD/Ton) by Type (2019-2024)
Table 29. Global Oligonucleotide Therapy Sales (Kilotons) by Application
Table 30. Global Oligonucleotide Therapy Market Size by Application
Table 31. Global Oligonucleotide Therapy Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Oligonucleotide Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Oligonucleotide Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Oligonucleotide Therapy Market Share by Application (2019-2024)
Table 35. Global Oligonucleotide Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Oligonucleotide Therapy Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Oligonucleotide Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Oligonucleotide Therapy Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Oligonucleotide Therapy Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Oligonucleotide Therapy Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Oligonucleotide Therapy Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Oligonucleotide Therapy Sales by Region (2019-2024) & (Kilotons)
Table 43. Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Basic Information
Table 44. Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Product Overview
Table 45. Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Alnylam Pharmaceuticals Inc. Business Overview
Table 47. Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy SWOT Analysis
Table 48. Alnylam Pharmaceuticals Inc. Recent Developments
Table 49. Biogen Oligonucleotide Therapy Basic Information
Table 50. Biogen Oligonucleotide Therapy Product Overview
Table 51. Biogen Oligonucleotide Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Biogen Business Overview
Table 53. Biogen Oligonucleotide Therapy SWOT Analysis
Table 54. Biogen Recent Developments
Table 55. Dynavax Technologies Corp. Oligonucleotide Therapy Basic Information
Table 56. Dynavax Technologies Corp. Oligonucleotide Therapy Product Overview
Table 57. Dynavax Technologies Corp. Oligonucleotide Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Dynavax Technologies Corp. Oligonucleotide Therapy SWOT Analysis
Table 59. Dynavax Technologies Corp. Business Overview
Table 60. Dynavax Technologies Corp. Recent Developments
Table 61. Merck and Co. Oligonucleotide Therapy Basic Information
Table 62. Merck and Co. Oligonucleotide Therapy Product Overview
Table 63. Merck and Co. Oligonucleotide Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Merck and Co. Business Overview
Table 65. Merck and Co. Recent Developments
Table 66. Miragen Therapeuutics Inc. Oligonucleotide Therapy Basic Information
Table 67. Miragen Therapeuutics Inc. Oligonucleotide Therapy Product Overview
Table 68. Miragen Therapeuutics Inc. Oligonucleotide Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Miragen Therapeuutics Inc. Business Overview
Table 70. Miragen Therapeuutics Inc. Recent Developments
Table 71. Sarepta Therapeutics Inc. Oligonucleotide Therapy Basic Information
Table 72. Sarepta Therapeutics Inc. Oligonucleotide Therapy Product Overview
Table 73. Sarepta Therapeutics Inc. Oligonucleotide Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Sarepta Therapeutics Inc. Business Overview
Table 75. Sarepta Therapeutics Inc. Recent Developments
Table 76. GlaxoSmithKline Oligonucleotide Therapy Basic Information
Table 77. GlaxoSmithKline Oligonucleotide Therapy Product Overview
Table 78. GlaxoSmithKline Oligonucleotide Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Recent Developments
Table 81. Pfizer Oligonucleotide Therapy Basic Information
Table 82. Pfizer Oligonucleotide Therapy Product Overview
Table 83. Pfizer Oligonucleotide Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Pfizer Business Overview
Table 85. Pfizer Recent Developments
Table 86. Gilead Sciences Oligonucleotide Therapy Basic Information
Table 87. Gilead Sciences Oligonucleotide Therapy Product Overview
Table 88. Gilead Sciences Oligonucleotide Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Gilead Sciences Business Overview
Table 90. Gilead Sciences Recent Developments
Table 91. Global Oligonucleotide Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 92. Global Oligonucleotide Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Oligonucleotide Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 94. North America Oligonucleotide Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Oligonucleotide Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 96. Europe Oligonucleotide Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Oligonucleotide Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 98. Asia Pacific Oligonucleotide Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Oligonucleotide Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 100. South America Oligonucleotide Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Oligonucleotide Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Oligonucleotide Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Oligonucleotide Therapy Sales Forecast by Type (2025-2030) & (Kilotons)
Table 104. Global Oligonucleotide Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Oligonucleotide Therapy Price Forecast by Type (2025-2030) & (USD/Ton)
Table 106. Global Oligonucleotide Therapy Sales (Kilotons) Forecast by Application (2025-2030)
Table 107. Global Oligonucleotide Therapy Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Oligonucleotide Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oligonucleotide Therapy Market Size (M USD), 2019-2030
Figure 5. Global Oligonucleotide Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Oligonucleotide Therapy Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oligonucleotide Therapy Market Size by Country (M USD)
Figure 11. Oligonucleotide Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Oligonucleotide Therapy Revenue Share by Manufacturers in 2023
Figure 13. Oligonucleotide Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Oligonucleotide Therapy Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Oligonucleotide Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Oligonucleotide Therapy Market Share by Type
Figure 18. Sales Market Share of Oligonucleotide Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Oligonucleotide Therapy by Type in 2023
Figure 20. Market Size Share of Oligonucleotide Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Oligonucleotide Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Oligonucleotide Therapy Market Share by Application
Figure 24. Global Oligonucleotide Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Oligonucleotide Therapy Sales Market Share by Application in 2023
Figure 26. Global Oligonucleotide Therapy Market Share by Application (2019-2024)
Figure 27. Global Oligonucleotide Therapy Market Share by Application in 2023
Figure 28. Global Oligonucleotide Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Oligonucleotide Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Oligonucleotide Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Oligonucleotide Therapy Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Oligonucleotide Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Oligonucleotide Therapy Sales Market Share by Country in 2023
Figure 37. Germany Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Oligonucleotide Therapy Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Oligonucleotide Therapy Sales Market Share by Region in 2023
Figure 44. China Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Oligonucleotide Therapy Sales and Growth Rate (Kilotons)
Figure 50. South America Oligonucleotide Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Oligonucleotide Therapy Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Oligonucleotide Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Oligonucleotide Therapy Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Oligonucleotide Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Oligonucleotide Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Oligonucleotide Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Oligonucleotide Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Oligonucleotide Therapy Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Oligonucleotide Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oligonucleotide Therapy Market Size (M USD), 2019-2030
Figure 5. Global Oligonucleotide Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Oligonucleotide Therapy Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oligonucleotide Therapy Market Size by Country (M USD)
Figure 11. Oligonucleotide Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Oligonucleotide Therapy Revenue Share by Manufacturers in 2023
Figure 13. Oligonucleotide Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Oligonucleotide Therapy Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Oligonucleotide Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Oligonucleotide Therapy Market Share by Type
Figure 18. Sales Market Share of Oligonucleotide Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Oligonucleotide Therapy by Type in 2023
Figure 20. Market Size Share of Oligonucleotide Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Oligonucleotide Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Oligonucleotide Therapy Market Share by Application
Figure 24. Global Oligonucleotide Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Oligonucleotide Therapy Sales Market Share by Application in 2023
Figure 26. Global Oligonucleotide Therapy Market Share by Application (2019-2024)
Figure 27. Global Oligonucleotide Therapy Market Share by Application in 2023
Figure 28. Global Oligonucleotide Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Oligonucleotide Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Oligonucleotide Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Oligonucleotide Therapy Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Oligonucleotide Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Oligonucleotide Therapy Sales Market Share by Country in 2023
Figure 37. Germany Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Oligonucleotide Therapy Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Oligonucleotide Therapy Sales Market Share by Region in 2023
Figure 44. China Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Oligonucleotide Therapy Sales and Growth Rate (Kilotons)
Figure 50. South America Oligonucleotide Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Oligonucleotide Therapy Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Oligonucleotide Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Oligonucleotide Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Oligonucleotide Therapy Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Oligonucleotide Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Oligonucleotide Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Oligonucleotide Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Oligonucleotide Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Oligonucleotide Therapy Market Share Forecast by Application (2025-2030)
